Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.7.0 is added to the history and the previous revision v3.6.6 is removed, updating the study record’s version history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision tag v3.6.6 was added to the study record history, while the previous revision v3.6.5 is removed from the list; this reflects an update to the page's versioning metadata in the history.SummaryDifference0.1%

- Check52 days agoChange DetectedThe study page's revision history shows a new Revision: v3.6.5, replacing v3.6.4. This reflects a software release update to the ClinicalTrials.gov page rather than changes to study content.SummaryDifference0.1%

- Check66 days agoChange DetectedA new Revision: v3.6.4 appears in the study record history, and Revision: v3.6.3 is removed. This update reflects an update to the record's version history.SummaryDifference0.1%

- Check88 days agoChange DetectedA new page revision is recorded (v3.6.3) replacing the earlier revision (v3.6.2) in the study's history. This reflects an update to the page metadata rather than substantive study details.SummaryDifference0.1%

- Check95 days agoChange DetectedThe revision history now shows a new entry for v3.6.2, replacing the prior v3.6.0 in the study record.SummaryDifference0.1%

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.